J. McNabb

Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia.

D. Nicolau, R. Quintiliani, C. Nightingale, 2001, International journal of antimicrobial agents.

Cost‐Effectiveness of Ceftazidime by Continuous Infusion versus Intermittent Infusion for Nosocomial Pneumonia

D. Nicolau, R. Quintiliani, C. Nightingale, 2001, Pharmacotherapy.

Streptococcus pneumoniae Response to Repeated Moxifloxacin or Levofloxacin Exposure in a Rabbit Tissue Cage Model

D. Xuan, M. Zhong, D. Nicolau, 2001, Antimicrobial Agents and Chemotherapy.

PHARMACOKINETICS OF CONTINUOUS AND INTERMITTENT CEFTAZIDIME IN INTENSIVE CARE UNIT PATIENTS WITH NOSOCOMIAL PNEUMONIA

D. Nicolau, R. Quintiliani, C. Nightingale, 1999 .

Patterns of adherence to antiretroviral medications: the value of electronic monitoring

J. Stoner, D. Nicolau, J. Ross, 2003, AIDS.

Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic.

D. Nicolau, C. Nightingale, J. Ross, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparison of azithromycin leukocyte disposition in healthy volunteers and volunteers with AIDS.

D. Xuan, R. Owens, D. Nicolau, 2000, International journal of antimicrobial agents.

Pharmacokinetics and Pharmacodynamics of Continuous and Intermittent Ceftazidime during the Treatment of Nosocomial Pneumonia

D. Nicolau, R. Quintiliani, C. Nightingale, 1999 .